Skip Navigation
Dispensary Info
Open
Pickup
Dispensary Info
Open
Pickup
Image of product

SUNO | Edible | PM | Tablets | 200mg

$22.49
$29.99
1

*Cannabis and Sales tax will be added at checkout.

THC is the primary cannabinoid responsible for the psychoactive effects associated with cannabis. The amount of THC in a product can vary widely based on the method of consumption and the strain at the source of that product. The high that is produced is often enhanced by the “entourage effect” which is a combination of multiple cannabinoids in conjunction with various terpenes and individual body chemistry.

CBD is the second most prevalent cannabinoid and is primarily produced by hemp plants and at lower amounts in cannabis. CBD has soared in popularity due to its non-psychoactive effects.

SUNO PM Tablets 200mg are a mess-free, strain-specific formulation containing 200mg of total THC per bottle across 20 tablets.

Dosage: Each small pill delivers an accurate 10mg dose, removing the sticky mess of traditional concentrates

Effects: offers enhanced therapeutic and entourage effects via natural terpenes.

Onset: Typically takes 45 minutes to 2 hours to activate as it processes through the digestive system

Cannabinoids

Cannabinoids are naturally occurring chemical compounds that are found in cannabis and provide consumers with a wide range of effects. THC and CBD are examples of some of the most commonly known cannabinoids.

About the Brand
SUNO Logo

SUNO is designed with Wellness in mind and committed to providing high quality cannabis products for every need.

Established out of a desire to provide dependable and consistent pharmaceutical grade cannabis based medicines to patients seeking treatment for chronic ailments. With over 50+ combined years in the cannabis industry, their teams expertise in cannabis extraction and isolation enables them to provide confidence in your choice to medicate accurately and effectively.

To make a positive impact in the lives of people through continuous research efforts, the development of innovative medicines, and characterization of disease specific cannabis-based treatment plans. They are committed to being the leader in medicinal cannabis, and are dedicated to shaping the future of the industry by providing clinically relevant alternative wellness options.